Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
D000328:Adult; D000704:Analysis of Variance; D001480:Basal Ganglia Diseases / Q000494:pharmacology; D001835:Body Weight; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D004569:Electroencephalography; D005260:Female; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012919:Social Behavior / Q000187:drug effects; D013375:Substance Withdrawal Syndrome; D013881:Thioridazine / Q000008:administration & dosage / Q000627:therapeutic use; D014050:Toluene / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014787:Vision Tests
D006846:Hydrocarbons, Halogenated; D010880:Piperidines; D010919:Placebos; D014149:Tranquilizing Agents; D014050:Toluene; D013881:Thioridazine; D002746:Chlorpromazine